Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Thermo Fisher, Bio-Rad, and More

Premium

Thermo Fisher Scientific this week introduced its Thermo Scientific Vanquish UHPLC system, with which the company is targeted the high-end research market.

According to the company, the instrument offers 1,500 bar maximum pump pressure and flow rate up to 5mL per minute. The instrument also features SmartFlow pumping technology for reproducible retention times, both direct heating and forced air temperature controls, and the Chromeleon data system.


Bio-Rad this week launched its Bio-Plex Pro RBM Human Metabolic and Hormone Assays, seven multiplex immunoassay panels to a total of 39 analytes for use in research into metabolic and cardiovascular conditions.


Shimadzu has released its i-Series HPLC systems. The systems feature a new PC-free operating environment, allowing researchers to control them from smart devices and automate workflows from start-up to shutdown after analysis.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.